NEW YORK (GenomeWeb News) - Strategic Diagnostics has appointed Francis DiNuzzo to serve as president and CEO, and to sit on the company’s board of directors. He was named interim CEO earlier this year.
 
DiNuzzo formerly was executive VP and chief commercial officer, positions he took on in February 2008. He spent 26 years in the life and analytical sciences industries, and he has served as VP and GM of chemical solutions, consumables and services, and integrated biology solutions at Agilent Technologies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.